Donald E. Saunders Acquires 94 Shares of Chemed Co. (CHE) Stock

Chemed Co. (NYSE:CHE) Director Donald E. Saunders bought 94 shares of the firm’s stock in a transaction on Thursday, May 4th. The stock was purchased at an average price of $205.59 per share, with a total value of $19,325.46. Following the completion of the acquisition, the director now owns 9,886 shares of the company’s stock, valued at $2,032,462.74. The purchase was disclosed in a filing with the SEC, which is available through this link.

Shares of Chemed Co. (NYSE:CHE) traded up 0.068% during midday trading on Friday, hitting $197.445. 48,576 shares of the stock traded hands. The company has a market capitalization of $3.18 billion, a PE ratio of 28.968 and a beta of 1.21. Chemed Co. has a 12-month low of $126.54 and a 12-month high of $216.01. The firm’s 50 day moving average price is $193.08 and its 200 day moving average price is $171.39.

Chemed (NYSE:CHE) last issued its earnings results on Wednesday, April 26th. The company reported $1.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.78 by $0.04. Chemed had a return on equity of 23.95% and a net margin of 6.77%. The firm had revenue of $405.90 million for the quarter, compared to analyst estimates of $399.75 million. During the same period in the previous year, the company posted $1.62 earnings per share. The business’s revenue was up 4.0% on a year-over-year basis. Analysts expect that Chemed Co. will post $7.95 EPS for the current year.

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 14th. Investors of record on Thursday, May 25th will be paid a dividend of $0.26 per share. The ex-dividend date is Tuesday, May 23rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.53%. Chemed’s payout ratio is 16.59%.

COPYRIGHT VIOLATION WARNING: This report was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.chaffeybreeze.com/2017/05/19/donald-e-saunders-acquires-94-shares-of-chemed-co-che-stock-updated.html.

Hedge funds have recently added to or reduced their stakes in the stock. Van Berkom & Associates Inc. raised its stake in Chemed by 5.8% in the third quarter. Van Berkom & Associates Inc. now owns 474,136 shares of the company’s stock worth $66,886,000 after buying an additional 26,040 shares during the last quarter. Capital Fund Management S.A. raised its stake in Chemed by 7.9% in the third quarter. Capital Fund Management S.A. now owns 33,450 shares of the company’s stock worth $4,719,000 after buying an additional 2,442 shares during the last quarter. New Amsterdam Partners LLC NY raised its stake in Chemed by 29.7% in the third quarter. New Amsterdam Partners LLC NY now owns 27,017 shares of the company’s stock worth $3,811,000 after buying an additional 6,189 shares during the last quarter. Sei Investments Co. raised its stake in Chemed by 14.4% in the third quarter. Sei Investments Co. now owns 4,627 shares of the company’s stock worth $653,000 after buying an additional 582 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its stake in Chemed by 13.1% in the third quarter. TIAA CREF Investment Management LLC now owns 107,496 shares of the company’s stock worth $15,164,000 after buying an additional 12,474 shares during the last quarter. Institutional investors own 99.72% of the company’s stock.

Separately, Zacks Investment Research upgraded Chemed from a “hold” rating to a “buy” rating and set a $195.00 price target on the stock in a report on Monday, February 20th.

Chemed Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

5 Day Chart for NYSE:CHE

Receive News & Ratings for Chemed Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply